FrancophonIA/ELRC3.0 huggingface dataset:
English: Pegasys is usually used alone for hepatitis B infection but is taken in combination with other medicines for hepatitis C. For more information about when to use this medicine in adults and children, see the summary of product characteristics (SmPC).
Estonian: B-hepatiidi infektsiooni korral kasutatakse Pegasysi tavaliselt ainuravimina, kuid C-hepatiidi ravis kombineeritakse seda teiste ravimitega.
English: The marketing authorisation was renewed on 5 February 2003 and on 5 February 2008.
Estonian: Müügiluba uuendati 5. veebruaril 2003 ja 5. veebruaril 2008.
English: This summary was last updated in 12-2007.
Estonian: Kokkuvõtte viimane uuendus: 12-2007.
English: The pain relief may last for up to four months.
Estonian: Valu leevenemine võib püsida kuni neli kuud.
English: QUADRAMET has been studied in 373 patients in three main studies.
Estonian: QUADRAMETi kasutamist uuriti 373 patsiendil kolmes põhiuuringus.
English: The main measure of effectiveness was the reduction of pain.
Estonian: Efektiivsust mõõdeti põhiliselt valu vähenemisega.
English: Other information about QUADRAMET:
Estonian: Muu teave QUADRAMETi kohta:
English: The European Commission granted a marketing authorisation valid throughout the European Union for QUADRAMET to CIS bio international on 5 February 1998.
Estonian: Euroopa Komisjon väljastas QUADRAMETi müügiloa, mis kehtib kogu Euroopa Liidu territooriumil, ettevõttele CIS bio international 5. veebruaril 1998.
English: lexidronam pentasodium.
Estonian: pentanaatriumleksidronaam.
English: The medicine is given by slow intravenous injection (into a vein) over one minute.
Estonian: Ravimit manustatakse aeglase intravenoosse süstina ühe minuti jooksul.
English: The following side effects have also been reported: asthenia (weakness), nausea (feeling sick), vomiting, diarrhoea, peripheral oedema (fluid retention), headaches, hypotension (low blood pressure), dizziness, myasthenia (muscle weakness), confusion and sweating.
Estonian: On esinenud ka järgmisi kõrvaltoimeid: asteenia (nõrkus), iiveldus, oksendamine, kõhulahtisus, perifeersed tursed (vedelikupeetus), peavalud, hüpotensioon (madal vererõhk), pearinglus, müasteenia (lihaste nõrkus), segasus ja higistamine.
English: QUADRAMET is a radiopharmaceutical product.
Estonian: QUADRAMET on radiofarmatseutiline ravim.
English: The Committee recommended that QUADRAMET be given marketing authorisation.
Estonian: Komitee soovitas anda QUADRAMETile müügiloa.
English: Before receiving QUADRAMET patients should have a bone scan using bisphosphonates radiolabelled with technetium-99m [99mTc] as markers, to check that their metastases are of the type that QUADRAMET can be used for.
Estonian: Enne QUADRAMETi saamist tuleb patsientidele teha luu-uuring, milles on markeritena kasutatud tehneetsium-99m-iga [99mTc] radiomärgistatud bisfosfonaate, et kontrollida, kas nende metastaasid on sellist tüüpi, mille puhul võib kasutada QUADRAMETi.
English: This was measured using various means, such as visual or descriptive scales, analgesic (painkiller) use, and assessment by the doctor.
Estonian: Seda mõõdeti erinevatel viisidel, näiteks visuaalse või kirjeldava skaalaga, valuvaigistite kasutamisega ja arstipoolse hindamisega.
English: EUROPEAN PUBLIC ASSESSMENT REPORT (EPAR) QUADRAMET EPAR summary for the public
Estonian: EUROOPA AVALIK HINDAMISARUANNE QUADRAMET Kokkuvõte üldsusele
English: The main side effects of QUADRAMET are a reduction in red and white blood cell and platelet counts.
Estonian: QUADRAMETi põhilised kõrvaltoimed on punaste ja valgete vereliblede ja trombotsüütide arvu vähenemine.
English: As a result, the radiation brought by the samarium-153 can act locally and help to relieve the bone pain.
Estonian: Seetõttu võib samaarium-153 tekitatud kiirgus avaldada ainult paikset toimet ja aidata luuvalu leevendada.
English: It should not be used in pregnant women or in patients who have had chemotherapy or hemi-body external radiotherapy in the previous six weeks.
Estonian: Seda ei tohi kasutada rasedatel ega patsientidel, kes on saanud viimase kuue nädala jooksul keemiaravi või poolele kehale välist kiiritusravi.
English: QUADRAMET should not be used in people who may be hypersensitive (allergic) to EDTMP or to phosphonates (similar chemical compounds).
Estonian: QUADRAMETi ei tohi kasutada isikud, kellel võib esineda ülitundlikkust (allergiat) EDTMP või fosfonaatide (sarnased keemilised ühendid) suhtes.
English: When QUADRAMET is injected into a patient, the complex is distributed around the body via the bloodstream.
Estonian: Kui patsiendile süstitakse QUADRAMETi, jaguneb kompleks vereringe kaudu organismis laiali.
English: The dose of QUADRAMET is calculated based on the patient's body weight to provide a specific dose of radioactivity (37 mega becquerels per kilogram body weight).
Estonian: QUADRAMETi annus arvutatakse patsiendi kehakaalu alusel, et määrata spetsiifiline radioaktiivsuse annus (37 megabekrelli kehakaalu kilogrammi kohta).
English: Because EDMTP has a high affinity for bone tissue, it accumulates in the bone, especially in areas of rapid bone growth such as osteoblastic metastases.
Estonian: Kuna EDMTP-l on luukoe suhtes kõrge afiinsus, koguneb see luudesse, eriti kiire luukasvuga piirkondadesse, näiteks osteoblastiliste metastaaside aladele.
English: Osteoblastic metastases are a type of bone metastasis where new bone tissue grows rapidly.
Estonian: Osteoblastilised metastaasid on luumetastaaside liik, mille puhul uus luukude kasvab kiiresti.
English: Patients who respond to QUADRAMET generally have relief of their pain within one week of treatment.
Estonian: QUADRAMETi toimele alluvate patsientide valu leevendub tavaliselt ühe nädala jooksul alates ravi saamisest.
English: In two of these, the effectiveness of QUADRAMET was compared with that of placebo (a dummy treatment).
Estonian: Neist kahes võrreldi QUADRAMETi efektiivsust platseebo (näiv ravim) efektiivsusega.
English: In one of the studies, which involved patients with bone metastases from prostate cancer, the patients' use of opioid analgesics (such as morphine) was also reduced following treatment with QUADRAMET.
Estonian: Ühes uuringus, milles osalesid eesnäärmevähi luumetastaasidega patsiendid, vähenes patsientidel pärast ravi QUADRAMETiga ka opioidide (näiteks morfiini) valuvaigistitena kasutamine.
English: It is a complex (a type of chemical) made up of a radioactive element, samarium-153 (153Sm), bound to another chemical called ‘ethylene diamine tetra methylene phosphonic acid'
Estonian: See on keemiline kompleks (keemiliste ainete liik), milles radioaktiivne element samaarium-153 (153Sm) on seotud teise keemilise aine, etüleendiamiin tetrametüleenfosfoonhappega (EDTMP).
English: QUADRAMET is used to relieve bone pain in patients with multiple painful osteoblastic skeletal metastases (when cancer has spread to the bones).
Estonian: QUADRAMETi kasutatakse luuvalu leevendamiseks patsientidel, kellel on hulgi valulikke osteoblastilisi luumetastaase (kui vähk on luudesse levinud).
English: Why has QUADRAMET been approved?
Estonian: Miks QUADRAMET heaks kiideti?
English: QUADRAMET should not be used at the same time as any chemotherapy that affects the bone marrow or at the same time as other bisphosphonate medicines if these can interact with the way QUADRAMET fixes to bone metastases.
Estonian: QUADRAMETi ei tohi kasutada üheaegselt luuüdi mõjutava keemiaraviga ega üheaegselt teiste bisfosfonaatravimitega, sest need võivad mõjutada QUADRAMETi seondumist luumetastaasidega.
English: What is the risk associated with QUADRAMET?
Estonian: Millised on QUADRAMETiga kaasnevad riskid?
English: What is QUADRAMET?
Estonian: Mis on QUADRAMET?
English: QUADRAMET was effective in providing pain relief from osteoblastic bone metastases, and, where it was compared with placebo, more effective than placebo.
Estonian: QUADRAMET leevendas efektiivselt osteoblastiliste luumetastaaside põhjustatud valu ning QUADRAMETi võrdlemisel platseeboga oli see platseebost efektiivsem.
English: The Committee for Medicinal Products for Human Use (CHMP) decided that QUADRAMET's benefits are greater than its risks for the relief of bone pain in patients with multiple painful osteoblastic skeletal metastases.
Estonian: Inimtervishoius kasutatavate ravimite komitee jõudis otsusele, et QUADRAMETi kasulikkus luuvalude leevendamisel patsientidel, kellel on hulgi valulikke osteoblastilisi luumetastaase, on suurem kui sellega kaasnevad riskid.
English: QUADRAMET is only used in bone metastases that can take up a type of chemical called bisphosphonates, as this means that the metastases will also take up QUADRAMET.
Estonian: QUADRAMETi kasutatakse ainult luumetastaaside puhul, mis on vastuvõtlikud bisfosfonaatidele, kuna see tähendab, et need metastaasid alluvad ka QUADRAMETile.
English: Its active substance is samarium [153Sm] lexidronam pentasodium.
Estonian: Selle toimeaine on samaarium [153Sm]
English: For the full list of all side effects reported with QUADRAMET, see the Package Leaflet.
Estonian: QUADRAMETi kohta teatatud kõrvalnähtude täieliku loetelu leiate pakendi infolehelt.
English: How does QUADRAMET work?
Estonian: Kuidas QUADRAMET toimib?
English: The full EPAR for QUADRAMET is available here.
Estonian: Euroopa avaliku hindamisaruande täisteksti QUADRAMETi kohta leiate siit.
English: What benefit has QUADRAMET shown during the studies?
Estonian: Milles seisneb uuringute põhjal QUADRAMETi kasulikkus?
English: QUADRAMET should only be handled and given by someone who is authorised to use radioactive medicines and after full oncological (cancer) evaluation.
Estonian: QUADRAMETi tohib käsitseda ja manustada vaid isik, kellel on lubatud kasutada radiomärgistatud ravimeid.
English: How is QUADRAMET used?
Estonian: Kuidas QUADRAMETi kasutatakse?
English: What is QUADRAMET used for?
Estonian: Milleks QUADRAMETi kasutatakse?
English: How has QUADRAMET been studied?
Estonian: Kuidas QUADRAMETi uuriti?
English: If you have the impression that the effect of Lansoprazol AbZ is too strong or too weak, please talk to your doctor.
Estonian: Kui teile tundub, et Lansoprazol AbZ'i toime on kas liiga tugev või liiga nõrk, konsulteerige palun oma arstiga.
English: Lansoprazol AbZ-Pharma 15 mg, 30 mg, gastro-resistant capsules, hard were referred for arbitration according to Article 29 of Council Directive 2001/83/EC, as amended, following concerns raised by Germany during a Mutual Recognition Procedure with Finland acting as Reference Member state.
Estonian: Lansoprazol AbZ-Pharma 15 mg, 30 mg gastroresistentsete kõvakapslite küsimus suunati lahendamiseks vastavalt nõukogu muudetud direktiivi 2001/83/EÜ artiklile 29 pärast Saksamaa poolt vastastikuse tunnustamise menetluses Soomega kui võrdlusliikmesriigiga tõstatatud probleeme.
English: Lansoprazol AbZ should be taken on an empty stomach (before meals).
Estonian: Lansoprazol AbZ tuleb sisse võtta tühja kõhuga (enne sööki).
English: Like all medicines, Lansoprazol AbZ can cause side effects, although not everybody gets them.
Estonian: Sarnaselt kõigi teist ravimitega võib ka Lansoprazol AbZ põhjustada kõrvaltoimete teket, kuigi mitte kõigil patsientidel.
English: If you forget to take Lansoprazol AbZ Do not take a double dose to make up for a forgotten dose.
Estonian: Kui te unustasite Lansoprazol AbZ'i sisse võtta Ärge võtke unustatud ravimi kompenseerimiseks topeltannust.
English: The risk/benefit ratio of Lansoprazol AbZ-Pharma 15 mg, 30 mg is considered to be favourable provided that appropriate information regarding H. pylori eradication therapy are included in the SPC.
Estonian: Lansoprazol AbZ-Pharma 15 mg, 30 mg kasulikkuse ja riski suhet loetakse soodsaks, tingimusel et ravimi omaduste kokkuvõte sisaldab asjakohast teavet H. pylori eradikatsioonravi kohta.
English: Taking Lansoprazol AbZ with food and drink:
Estonian: Lansoprazol AbZ'i kasutamine söögi ja joogiga:
English: Always take Lansoprazol AbZ exactly as your doctor has told you.
Estonian: Võtke Lansoprazol AbZ'i alati täpselt vastavalt teie arsti ettekirjutustele.
English: The inhibition is dosedependent and reversible, and the effect applies to both basal and stimulated secretion of gastric acid.
Estonian: Inhibeerimine sõltub annusest ning on pöörduv, ravim toimib nii maohappe basaalsele kui ka stimuleeritud sekretsioonile.
English: It is recommended that you take Lansoprazol AbZ before meals, as simultaneous food intake reduces the availability of lansoprazole to the body.
Estonian: Lansoprazol AbZ on soovitatav sisse võtta enne söögikorda, sest samaaegne söömine vähendab lansoprasooli biosaadavust.
English: Fluvoxamine (a medicine for the treatment of depression), ketoconazole and itraconazole (medicines for the treatment of fungal infections), protease inhibitors (active substances used in the treatment of the AIDS virus) and macrolides (certain types of antibiotics) may markedly raise the concentration of lansoprazole in the blood and thus increase the effect of Lansoprazol AbZ.
Estonian: Fluvoksamiin (depressiooni ravim), ketokonasool ja itrakonasool (seeninfektsioonide vastased ravimid), proteaasi inhibiitorid (AIDS-i viiruse vastaste ravimite toimeained) ja makroliidid (teatud tüüpi antibiootikumid) võivad märkimisväärselt tõsta lansoprasooli kontsentratsiooni veres ning seeläbi suurendada Lansoprazol AbZ'i toimet.
English: Lansoprazol AbZ capsules are swallowed whole with sufficient liquid (e.g. a glass of water).
Estonian: Lansoprazol AbZ kapslid tuleb alla neelata tervena piisava koguse vedelikuga (näiteks klaasitäis vett).
English: Intake of Lansoprazol AbZ may mask the symptoms of a tumour and delay diagnosis of this condition
Estonian: Lansoprazol AbZ'i kasutamine võib peita kasvaja sümptomeid ning edasi lükata diagnoosimist
English: When making a decision as to whether breastfeeding or therapy with Lansoprazol AbZ should be continued or discontinued, the benefits of breastfeeding for the child and the benefits of therapy with Lansoprazol AbZ for the mother should be considered.
Estonian: Imetamise või ravi Lansoprazol AbZ'i jätkamise või katkestamise otsuse tegemisel tuleb arvestada rinnaga toitmise kasu lapsele ning Lansoprazol AbZ'i ravi kasu emale.
English: Important information about some of the ingredients of Lansoprazol AbZ This medicine contains sucrose.
Estonian: Oluline info mõne Lansoprazol AbZ'i koostisosa kohta Ravim sisaldab sahharoosi.
English: During treatment with Lansoprazol AbZ, side effects such as light-headedness and fatigue may occur (see section 4.
Estonian: Lansoprazol AbZ ravi ajal võivad esineda kõrvaltoimed nagu uimasus ja väsimus (vaata lõik 4 “Kõrvaltoimed”).
English: The effect of Lansoprazol AbZ may be influenced by the following medicines or drug groups:
Estonian: Lansoprazol AbZ'i toimet võivad muuta järgmised ravimid või ravimgrupid
English: If you take more Lansoprazol AbZ than you should you should always consult a doctor.
Estonian: Kui te olete sisse võtnud rohkem Lansoprazol AbZ'i kui te võisite, siis konsulteerige alati arstiga.
English: What Lansoprazol AbZ looks like and contents of the pack
Estonian: Kuidas Lansoprazol AbZ välja näeb ja missugune on pakendi sisu
English: Use of Lansoprazol AbZ is not recommended during pregnancy.
Estonian: Lansoprazol AbZ'i kasutamine raseduse ajal ei ole soovitatav.
English: Lansoprazol AbZ is a medicine which reduces the amount of acid made by the stomach (selective proton pump inhibitor).
Estonian: Lansoprazol AbZ on ravim, mis vähendab mao poolt toodetava happe hulka (selektiivne prootonpumba inhibiitor).
English: Lansoprazol AbZ may not be used in children, as its safety and efficacy have not been established in this patient group.
Estonian: Lansoprazol AbZ'i ei tohi lastel kasutada, sest ravimi kasutamise ohutus ja efektiivsus selles patsiendigrupis ei ole tõestatud.
English: Patients with severely impaired liver function should not take Lansoprazol AbZ, nor should they be given combination therapy with clarithromycin.
Estonian: Raske maksatalitluse häirega patsiendid ei tohi Lansoprazol AbZ'i kasutada, samuti ei tohi neile määrata kombineeritud ravi klaritromütsiiniga.
English: Take special care with Lansoprazol AbZ - if you have impaired liver function (see section 3.
Estonian: Olge Lansoprazol AbZ kasutamisel väga ettevaatlik - kui teil on maksatalitluse häired (vaata lõik 3.
English: OVERALL SUMMARY OF THE SCIENTIFIC EVALUATION OF LANSOPRAZOL ABZPHARMA 15 MG, 30 MG, GASTRO-RESISTANT CAPSULES, HARD (see Annex I)
Estonian: ÜLDINE KOKKUVÕTE LANSOPRAZOL ABZ-PHARMA 15 MG, 30 MG GASTRORESISTENTSETE KÕVAKAPSLITE TEADUSLIKUST HINDAMISEST (vt I lisa)
English: the CHMP has recommended the granting of the Marketing Authorisations for which the Summary of Product Characteristics, labelling and package leaflet are set out in Annex III for Lansoprazol AbZPharma and associated names (see Annex I).
Estonian: on inimtervishoius kasutatavate ravimite komitee soovitanud anda müügiload Lansoprazol AbZPharma'le ja sellega seotud nimetustele (vt I lisa), mille ravimiomaduste kokkuvõte, märgistus ja pakendi infoleht on esitatud III lisas.
English: - if you use Lansoprazol AbZ in combination therapy with antibiotics to eradicate Helicobacter pylori, you should carefully read the package leaflets of these antibiotics, too - if you take Lansoprazol AbZ for longer than 1 year, therapy should be regularly monitored and the doctor should carefully consider the benefit versus risk ratio - if you experience any problems with your eyesight following long-term use (longer than 1 year), treatment with Lansoprazol AbZ should be promptly discontinued and you should consult an ophthalmologist.
Estonian: “Kuidas kasutada Lansoprazol AbZ'i”) - kui te kasutate Lansoprazol AbZ'i kombinatsioonis antibiootikumidega Helicobacter pylori eradikatsiooni eesmärgil, peate te tähelepanelikult läbi lugema ka samaaegselt kasutatavate antibiootikumide pakendite infolehed - kui te kasutate Lansoprazol AbZ'i pikemat aega kui 1 aasta, peab ravi regulaarselt jälgima ning konsulteerima arstiga kasude riskide suhte hindamiseks.
English: Lansoprazol AbZ is not recommendes for use in children, as its safety and efficacy have not been established in this patient group.
Estonian: Lansoprazol AbZ'i kasutamine lastel ei ole soovitatav, sest ravimi kasutamise ohutus ja efektiivsus selles patsiendigrupis ei ole tõestatud.
English: - Before treatment with Lansoprazol AbZ - the diagnosis of ulcers of the duodenum or stomach and inflammation of the gullet due to reflux of stomach acid should be confirmed by gastroscopy or other appropriate diagnostic measures (e.g. X-ray with contrast media) - a stomach ulcer with Lansoprazol AbZ, the possibility of a malignant stomach tumour should be excluded.
Estonian: - Mida on vaja teada enne ravi Lansoprazol AbZ'iga - kaksteistsõrmiksoole haavandi või maohaavandi ning maohappe tagasivoolust tingitud söögitorupõletiku diagnoos peavad olema kinnitatud gastroskoopial või teiste sobivate diagnostiliste meetodite abil (näiteks kontrastainega röntgenoloogiline uuring) - maohaavandi ravi korral Lansoprazol AbZ'iga peab olema välistatud pahaloomulise maokasvaja olemasolu.
English: What Lansoprazol AbZ contains
Estonian: Mida Lansoprazol AbZ sisaldab
English: Do not use Lansoprazol AbZ after the expiry date which is stated on the carton and the blister.
Estonian: Ärge kasutage Lansoprazol AbZ'i pärast ravimi karbil ja blisterpakendil märgitud kõlblikkusaja möödumist.
English: You should avoid breastfeeding while taking Lansoprazol AbZ, as there has been insufficient experience with its use during lactation.
Estonian: Lansoprazol AbZ'i kasutamist rinnaga toitmise ajal tuleb vältida, sest ravimi kasutamise kogemus imetamise ajal on ebapiisav.
English: Lansoprazol AbZ is given:
Estonian: Lansoprazol AbZ kasutatakse:
English: Treatment with Lansoprazol AbZ therefore leads to a slightly increased risk of infections in the gastrointestinal tract, such as with salmonella and Campylobacter.
Estonian: Ravi Lansoprazol AbZ'iga võib vähesel määral suurendada näiteks Salmonella'st ja Campylobacter'ist põhjustatud gastrointestinaalsete infektsioonide tekke riski.
English: INFORMATION IN BRAILLE < Lansoprazol AbZ 30 mg > [to be completed nationally]
Estonian: INFO BRAILLE KIRJAS < Lansoprazol AbZ 30 mg > [täidetakse riiklikult]
English: What Lansoprazol AbZ is and what it is used for Before you take Lansoprazol AbZ How to take Lansoprazol AbZ Possible side effects
Estonian: Mis ravim on Lansoprazol AbZ ja milleks seda kasutatakse Mida on vaja teada enne Lansoprazol AbZ'i kasutamist Kuidas Lansoprazol AbZ'i kasutada Võimalikud kõrvaltoimed
English: INFORMATION IN BRAILLE < Lansoprazol AbZ 15 mg > [to be completed nationally]
Estonian: INFO BRAILLE KIRJAS < Lansoprazol AbZ 15 mg > [täidetakse riiklikult]
English: Ketoconazole and itraconazole (medicines for the treatment of fungal infections) The combination of lansoprazole and ketoconazole or itraconazole should be avoided, as the reduction in stomach acid caused by intake of Lansoprazol AbZ may impair the absorption of the other medicines into the blood, thus leading to an underdose.
Estonian: Ketokonasool ja itrakonasool (seeninfektsioonide vastased ravimid) Lansoprasooli ja ketokonasooli või itrakonasooli samaaegset kasutamist tuleb vältida, sest Lansoprazol AbZ'i kasutamisest tingitud mao happesisalduse langus võib takistada nimetatud teiste ravimite imendumist ning põhjustada ebapiisavat annustamist.
English: At the beginning or end of simultaneous use of Lansoprazol AbZ, plasma tacrolimus concentrations should be monitored.
Estonian: Lansoprazol AbZ'i kasutamise alguses või lõpus peab jälgima takroliimuse plasmakontsentratsioone.
English: Lansoprazol AbZ 30 mg Hartkapseln 30 mg Gastro-resistant capsule, hard Oral use
Estonian: Lansoprazol AbZ 30 mg Hartkapseln 30 mg Gastroresistentsed kõvakapslid Peroraalne
English: Lansoprazol AbZ 15 mg Hartkapseln 15 mg Gastro-resistant capsule, hard Oral use
Estonian: Lansoprazol AbZ 15 mg Hartkapseln 15 mg Gastroresistentsed kõvakapslid Peroraalne
English: WHAT Lansoprazol AbZ IS AND WHAT IT IS USED FOR
Estonian: MIS RAVIM ON Lansoprazol AbZ JA MILLEKS SEDA KASUTATAKSE
English: If you stop taking Lansoprazol AbZ
Estonian: Kui te lõpetate Lansoprazol AbZ'i kasutamise
English: < Lansoprazol AbZ and associated names (see Annex I) 15 mg , gastro-resistant capsules, hard > < Lansoprazol AbZ and associated names (see Annex I) 30 mg , gastro-resistant capsules, hard >
Estonian: < Lansoprazol AbZ ja sarnased nimed (vaata I Lisa) 15 mg gastroresistentne kõvakapsel > < Lansoprazol AbZ ja sarnased nimed (vaata I Lisa) 30 mg gastroresistentne kõvakapsel >
English: ratiopharm GmbH Graf-Arco-Strasse 3 D-89079 Ulm Germany
Estonian: ratiopharm GmbH Graf-Arco-Strasse 3 D-89079 Ulm Saksamaa
English: Do not take Lansoprazol AbZ - if you are allergic (hypersensitive) to Lansoprazol or any of the other ingredients of
Estonian: - kui te olete allergiline (liiga tundlik) lansoprasoolile või Lansoprazol AbZ'i teistele koostisosadele.
English: Uncommon less than 1 in 100, but more than 1 in 1,000 treated patients
Estonian: Väga sage rohkem kui 1 patsiendil 10 ravitud patsiendist Sage vähem kui 1 inimesel 10 ravitust, kuid rohkemal kui 1 inimesel 100 ravitud patsiendist
English: Germany ratiopharm GmbH Graf-Arco-Str. 3 89075 Ulm Germany
Estonian: Saksamaa ratiopharm GmbH Graf-Arco-Str. 3 89075 Ulm Saksamaa
English: 15 mg Gastro-resistant capsule, hard Oral use
Estonian: 15 mg Gastroresistentsed kõvakapslid Peroraalne
English: 30 mg Gastro-resistant capsule, hard Oral use
Estonian: 30 mg Gastroresistentsed kõvakapslid Peroraalne
English: How to store Lansoprazol AbZ Further information
Estonian: Kuidas Lansoprazol AbZ'i säilitada Lisainfo
English: HOW TO TAKE Lansoprazol AbZ
Estonian: KUIDAS Lansoprazol AbZ'i KASUTADA
English: Finland ratiopharm GmbH Graf-Arco-Str. 3 89075 Ulm Germany
Estonian: Soome ratiopharm GmbH Graf-Arco-Str. 3 89075 Ulm Saksamaa